Outcomes of Different Haploidentical Transplantation Strategies from the Taiwan Blood and Marrow Transplantation Registry

SIMPLE SUMMARY: Haploidentical hematopoietic stem cell transplantation haplo-HSCT is now increasingly recognized as a valid treatment for patients with hematologic malignancies. The two most noteworthy strategies are posttransplantation cyclophosphamide (PTCy) with or without anti-thymoglobulin and...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Xavier Cheng-Hong, Chen, Tzu-Ting, Gau, Jyh-Pyng, Wang, Po-Nan, Liu, Yi-Chang, Lien, Ming-Yu, Li, Chi-Cheng, Yao, Ming, Ko, Bor-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870072/
https://www.ncbi.nlm.nih.gov/pubmed/35205845
http://dx.doi.org/10.3390/cancers14041097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870072/
https://www.ncbi.nlm.nih.gov/pubmed/35205845
http://dx.doi.org/10.3390/cancers14041097

Ejemplares similares